- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hematologic Disease in United States
Total 147311 results
-
Emory UniversityCompletedHematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Scripps Translational Science InstituteCompleted
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM)CompletedHematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood CancerUnited States
-
Julie-An M. TalanoMiltenyi Biotec, Inc.Active, not recruitingHematologic MalignanciesUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematologic MalignanciesUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedHematologic MalignanciesUnited States
-
University of UtahTerminatedHigh Risk Hematologic MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLeukemia | Cancer | Non-Hodgkin's Lymphoma | Myelodysplastic SyndromeUnited States
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
M.D. Anderson Cancer CenterTerminatedFatigue | Advanced Cancer | Hematologic MalignancyUnited States
-
Duke UniversityRecruiting
-
Ronald PaquetteRecruitingHematologic MalignanciesUnited States
-
University of California, San DiegoSuspendedHematologic MalignanciesUnited States
-
Duke UniversityCompletedA Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital CareHematologic MalignanciesUnited States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
University of Michigan Rogel Cancer CenterCompletedHematologic Neoplasms | Graft vs Host Disease | Non-Neoplastic Hematologic and Lymphocytic DisorderUnited States
-
Fred Hutchinson Cancer CenterRecruitingNon-Neoplastic Hematologic and Lymphocytic DisorderUnited States
-
Kiromic, Inc.WithdrawnCancer | Hematologic MalignanciesUnited States
-
St. Jude Children's Research HospitalCompletedAcute Myeloid Leukemia | Bone Marrow Transplantation | Hematologic MalignancyUnited States
-
Baptist Health South FloridaWithdrawnNon-Hodgkin Lymphoma | Hematologic Malignancy | B-Cell Lymphoid MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedHematologic MalignanciesUnited States
-
Anne Beaven, MDNovartisWithdrawnHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingCancer | Hematologic Malignancy | Blood Cancer | Tumor, SolidUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)RecruitingHematologic MalignanciesUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Completed
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Completed
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...CompletedHematologic Malignancies | Graft Versus Host DiseaseUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedHematologic MalignancyUnited States
-
University of RochesterRecruitingHematologic MalignanciesUnited States
-
University of OklahomaCompletedHematologic MalignancyUnited States
-
Stanford UniversityCompletedLeukemia | Blood CancerUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedGraft vs Host Disease | Hematologic NeoplasmUnited States
-
Mayo ClinicRecruitingSolid Tumors | Hematologic MalignanciesUnited States
-
Community Cancer CareAmgenUnknownCancer | Solid Tumor | Hematologic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedHematologic Malignancy | Myeloproliferative DisorderUnited States
-
University of Colorado, DenverRecruitingHematologic DisordersUnited States
-
Kah Poh LohWithdrawn
-
Tarix PharmaceuticalsWithdrawnHematologic Malignancy | Cord Blood Transplant | Inherited Metabolic DiseaseUnited States
-
Fate TherapeuticsTerminatedA Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesHematologic MalignanciesUnited States
-
National Cancer Institute (NCI)Enrolling by invitationSolid Tumors | Hematologic Malignancies | Pediatric CancersUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematopoietic/Lymphoid CancerUnited States
-
Dialectic Therapeutics, IncCompletedSolid Tumor | Hematologic MalignancyUnited States
-
St. Jude Children's Research HospitalAssisi FoundationCompletedLymphoma | LeukemiaUnited States
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
University of ChicagoTerminatedHematologic MalignanciesUnited States
-
St. Jude Children's Research HospitalCompletedCancer | Hematologic DisordersUnited States
-
Nationwide Children's HospitalActive, not recruitingHematologic Malignancy | MyelodysplasiaUnited States